Terns Pharmaceuticals Alternatives & Competitors
12 companies similar to Terns Pharmaceuticals — Taking the Journey Towards Comprehensive Treatment of Serious Disease
Companies similar to Terns Pharmaceuticals
Seattle, United States
Domain Therapeutics
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression
Illkirch-graffenstaden, F...
Poolbeg Pharma plc
Focused on the development & commercialisation of innovative medicines. Ticker: POLB
London, United Kingdom
ESCAPE Bio
A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEUROD...
South San Francisco, Unit...
Track all Terns Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Treadwell Therapeutics, Inc.
The Path to Better
New York, United States
Longboard Pharmaceuticals
We Are Committed To Transforming the Lives of Patients With Neurological and Rare Diseases...
La Jolla, United States
Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...
Ocuphire Pharma
Restoring Vision and Clarity
Farmington Hills, United...
Helicore Biopharma
Long-Acting Medicines to Transform Metabolic Health
San Mateo, United States
Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
Princeton, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
About Terns Pharmaceuticals
Terns Pharmaceuticals is a United States based biopharmaceutical company established in 2016. The company's primary focus is on developing a diverse portfolio of small-molecule product candidates targeting oncology and obesity. Currently, Terns Pharmaceuticals has three clinical-stage development programs, including an...
Biopharmaceutical, Clinical-stage, Oncology, Obesity, Small-molecule Product Candidates, Allosteric BCR-ABL Inhibitor, GLP-1 Receptor Agonist, THR-β Agonist, GIPR Modulator Programs
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Terns Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Terns Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
